PPARA and Insulin resistance: Jansen’s team (Jansen et al., 2023) observed that 1,2-Dilinoleoyl-sn-glycero-3-phosphocholine enhances adipocyte catabolism and apoptosis through a TNF-α-dependent pathway, thereby alleviating insulin resistance via PPARα-mediated inhibition of myocyte inflammation.